Table 1.

Characteristics of the study groups.

Sample	Source name	Age	Gender	EF%	CI	Inflammation/PVB19
1	Healthy control	36	Female	68	−	Negative
2	Healthy control	46	Female	61	−	Negative
3	Healthy control	26	Female	74	−	Negative
4	Healthy control	36	Male	64	−	Negative
5	DCMi	45	Male	34	+	Positive
6	DCMi	62	Male	51	+	Positive
7	DCMi	31	Male	52	+	Positive
8	DCMi	67	Male	43	+	Positive
9	DCMi	60	Male	34	+	Positive
10	DCMi	69	Male	35	+	Positive
11	DCMi	55	Female	31	+	Positive
12	DCMi	31	Female	56	+	Positive

DCMi; inflammatory cardiomyopathy, EF; ejection fraction, CI; cardiac inflammation, PVB19; parvovirus B19.